Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;476(6):889-899.
doi: 10.1007/s00424-024-02928-x. Epub 2024 Feb 23.

Only bioactive forms of PTH (n-oxPTH and Met18(ox)-PTH) inhibit synthesis of sclerostin - evidence from in vitro and human studies

Affiliations

Only bioactive forms of PTH (n-oxPTH and Met18(ox)-PTH) inhibit synthesis of sclerostin - evidence from in vitro and human studies

Mei Li et al. Pflugers Arch. 2024 Jun.

Abstract

Sclerostin (SOST) is produced by osteocytes and is known as a negative regulator of bone homeostasis. Parathyroid hormone (PTH) regulates calcium, phosphate as well as vitamin D metabolism, and is a strong inhibitor of SOST synthesis in vitro and in vivo. PTH has two methionine amino acids (positions 8 and 18) which can be oxidized. PTH oxidized at Met18 (Met18(ox)-PTH) continues to be bioactive, whereas PTH oxidized at Met8 (Met8(ox)-PTH) or PTH oxidized at Met8 and Met18 (Met8, Met18(di-ox)-PTH) has minor bioactivity. How non-oxidized PTH (n-oxPTH) and oxidized forms of PTH act on sclerostin synthesis is unknown. The effects of n-oxPTH and oxidized forms of PTH on SOST gene expression were evaluated in UMR106 osteoblast-like cells. Moreover, we analyzed the relationship of SOST with n-oxPTH and all forms of oxPTH in 516 stable kidney transplant recipients using an assay system that can distinguish in clinical samples between n-oxPTH and the sum of all oxidized PTH forms (Met8(ox)-PTH, Met18(ox)-PTH, and Met8, Met18(di-ox)-PTH). We found that both n-oxPTH and Met18(ox)-PTH at doses of 1, 3, 20, and 30 nmol/L significantly inhibit SOST gene expression in vitro, whereas Met8(ox)-PTH and Met8, Met18(di-ox)-PTH only have a weak inhibitory effect on SOST gene expression. In the clinical cohort, multivariate linear regression showed that only n-oxPTH, but not intact PTH (iPTH) nor oxPTH, is independently associated with circulating SOST after adjusting for known confounding factors. In conclusion, only bioactive PTH forms such as n-oxPTH and Met18(ox)-PTH, inhibit SOST synthesis.

Keywords: KTRs; Non-oxidized; Oxidized; PTH; SOST.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The effects of n-oxPTH and various forms of oxPTH on SOST gene expression in UMR106 rat osteoblast-like cells (ad). We cultured the cells for the first 24 h, then, treated them with or without PTH 1–34 derivatives for another 24 h at 1, 3, 20, and 30 nmol/L, respectively. The experiment was repeated six times and the levels of SOST expression were measured by qRT-PCR. a and b Both n-oxPTH and Met18(ox)-PTH peptides, at all dosages caused a significant decrease in SOST gene expression when compared with negative controls (P < 0.001), however n-ox PTH had a maximum inhibitory effect already at 1 nmol/L; an extent of inhibition, that was not reached even with a dose of 30 nmol/L Met18(ox)-PTH peptides. c A similar trend was also observed in the Met18(di-ox)-PTH peptides, despite a relatively slight inhibition in comparison to negative controls (P < 0.05). d However, the Met8(ox)-PTH peptides inhibited the SOST mRNA synthesis even to a lesser extent and only at 20 and 30 nmol/L (P < 0.05), but not at 1 and 3 nmol/L, when compared with negative controls. The x-axis shows the different concentrations. The y-axis represents the relative SOST gene expression. Data was analyzed using the Kruskal–Wallis test followed by Dunn’s post-hoc test. * P < 0.05, ** P < 0.01, *** P < 0.001 vs. control group. # P < 0.05, 1 nmol/L vs. 3 nmol/L Met8(ox)-PTH peptides. Abbreviations: iPTH, intact PTH; n-oxPTH, non-oxidized PTH; oxPTH, oxidized PTH; PTH, parathyroid hormone; SOST, sclerostin
Fig. 2
Fig. 2
Histogram showing the frequency distribution of plasma iPTH (a), oxPTH (b), n-oxPTH (c), and Sclerostin (d) in 516 stable kidney transplant recipients. The actual concentrations of iPTH, oxPTH, and n-oxPTH in the study population are not normally distributed, except for SOST concentration, which is similar to a normal distribution. Abbreviations: iPTH, intact PTH; n-oxPTH, non-oxidized PTH; oxPTH, oxidized PTH; PTH, parathyroid hormone; SOST, sclerostin
Fig. 3
Fig. 3
Scatterplot showing the correlation between SOST and n-oxPTH plasma concentrations in kidney transplant recipients. As actual plasma SOST and n-oxPTH concentrations were moderately skewed in the study, we calculated ln-SOST and ln-n-oxPTH. After data transformation, both ln-SOST and ln-n-oxPTH were close to being normally distributed. We used Pearson correlation analysis to assess the associations between ln-SOST and ln-n-oxPTH. Our findings showed that ln-SOST was significantly negatively associated with ln-n-oxPTH (P < 0.05). Abbreviations: n-oxPTH, non-oxidized PTH; PTH, parathyroid hormone; SOST, sclerostin

Similar articles

Cited by

References

    1. Ardawi MS, Al-Sibiany AM, Bakhsh TM, et al. Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study. Osteoporos Int. 2012;23(6):1789–1797. doi: 10.1007/s00198-011-1806-8. - DOI - PubMed
    1. Bär L, Hase P, Föller M. PKC regulates the production of fibroblast growth factor 23 (FGF23) PLoS One. 2019;14(2019):e0211309. doi: 10.1371/journal.pone.0211309. - DOI - PMC - PubMed
    1. Belaya ZE, Rozhinskaya LY, Melnichenko GA, et al. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome. Osteoporos Int. 2013;24(8):2191–9. doi: 10.1007/s00198-013-2268-y. - DOI - PubMed
    1. Bellido T, Ali AA, Gubrij I, et al. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology. 2005;146(11):4577–4583. doi: 10.1210/en.2005-0239. - DOI - PubMed
    1. Bellido T, Ali AA, Plotkin LI, et al. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem. 2003;278(50):50259–50272. doi: 10.1074/jbc.M307444200. - DOI - PubMed

LinkOut - more resources